Circulating Malondialdehyde-Modified LDL-Related Variables and Coronary Artery Stenosis in Asymptomatic Patients with Type 2 Diabetes

Circulating Malondialdehyde-Modified LDL-Related Variables and Coronary Artery Stenosis in Asymptomatic Patients with Type 2 Diabetes

Aims. To elucidate the levels of malondialdehyde-modified LDL (MDA-LDL)-related variables for predicting coronary artery stenosis (CAS) by coronary CT angiography (CCTA) in asymptomatic patients with type 2 diabetes (T2DM). Methods. Enrolled were 36 Japanese patients with T2DM who underwent CCTA and...

Full description

Bibliographic Details
Main Authors:	Kazuya Fujihara, Hiroaki Suzuki, Akira Sato, Satoru Kodama, Yoriko Heianza, Kazumi Saito, Hitoshi Iwasaki, Kazuto Kobayashi, Shigeru Yatoh, Akimitsu Takahashi, Naoya Yahagi, Hiroaki Yagyu, Hirohito Sone, Hitoshi Shimano
Format:	Article
Language:	English
Published:	Hindawi Limited 2015-01-01
Series:	Journal of Diabetes Research
Online Access:	http://dx.doi.org/10.1155/2015/507245

Similar Items

Association of Helicobacter pylori Infection with Glycemic Control in Patients with Diabetes: A Meta-Analysis
by: Chika Horikawa, et al.
Published: (2014-01-01)

Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.
by: Noriko Suzuki-Kemuriyama, et al.
Published: (2016-01-01)

Deciphering genetic signatures by whole exome sequencing in a case of co-prevalence of severe renal hypouricemia and diabetes with impaired insulin secretion
by: Motohiro Sekiya, et al.
Published: (2020-05-01)

Cholesterol accumulation and diabetes in pancreatic β-cell-specific SREBP-2 transgenic mice: a new model for lipotoxicity
by: Mayumi Ishikawa, et al.
Published: (2008-12-01)

Protein kinase Cbeta mediates hepatic induction of sterol-regulatory element binding protein-1c by insulin
by: Takashi Yamamoto, et al.
Published: (2010-07-01)

Intestinal CREBH overexpression prevents high-cholesterol diet-induced hypercholesterolemia by reducing Npc1l1 expression
by: Takuya Kikuchi, et al.
Published: (2016-11-01)

The Relationship between Diabetic Neuropathy and Sleep Apnea Syndrome: A Meta-Analysis
by: Kazuya Fujihara, et al.
Published: (2013-01-01)

Quantitative Relationship Between Cumulative Risk Alleles Based on Genome-Wide Association Studies and Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
by: Satoru Kodama, et al.
Published: (2018-01-01)

Diabetes mellitus and risk of new‐onset and recurrent heart failure: a systematic review and meta‐analysis
by: Satoru Kodama, et al.
Published: (2020-10-01)

Structural and functional changes in LDL after modification with both 4-hydroxynonenal and malondialdehyde
by: HF Hoff, et al.
Published: (1993-07-01)

Cloning and characterization of a mammalian fatty acyl-CoA elongase as a lipogenic enzyme regulated by SREBPs
by: Takashi Matsuzaka, et al.
Published: (2002-06-01)

Isolation of low density lipoprotein (LDL) with its modification by Copper ion and Malondialdehyde (MDA)
by: Doosty M, et al.
Published: (1999-06-01)

Dual regulation of mouse Δ5- and Δ6-desaturase gene expression by SREBP-1 and PPARα
by: Takashi Matsuzaka, et al.
Published: (2002-01-01)

Gene-Diet Interaction and Precision Nutrition in Obesity
by: Yoriko Heianza, et al.
Published: (2017-04-01)

Comparative Binding Analysis of Dipeptidyl Peptidase IV (DPP-4) with Antidiabetic Drugs - An Ab Initio Fragment Molecular Orbital Study.
by: Sundaram Arulmozhiraja, et al.
Published: (2016-01-01)

Serum paraoxonase and malondialdehyde levels in asymptomatic cholelithiasis
by: Mehmet Agilli, et al.
Published: (2014-01-01)

Humoral immune response to heat shock protein 60 of Aggregatibacter actinomycetemcomitans and cross-reactivity with malondialdehyde acetaldehyde-modified LDL.
by: Mikael Kyrklund, et al.
Published: (2020-01-01)

Response to: Serum paraoxonase and malondialdehyde levels in asymptomatic cholelithiasis
by: Aytaç Atamer, et al.
Published: (2016-01-01)

Atheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccine1[S]
by: Ayelet Gonen, et al.
Published: (2014-10-01)

Hormone-sensitive lipase is involved in hepatic cholesteryl ester hydrolysis
by: Motohiro Sekiya, et al.
Published: (2008-08-01)

Evaluation of paraoxonase, malondialdehyde, and lipoprotein levels in patients with asymptomatic cholelithiasis
by: Aytac Atamer, et al.
Published: (2014-01-01)

The effect of Sorghum Tempeh (Sorghum bicolor L. Moench) on low-density lipoprotein (LDL) and malondialdehyde (MDA) levels in atherogenic diet-induced rats
by: Ana Khoirun Nisa, et al.
Published: (2021-09-01)

Machine Learning Approach to Decision Making for Insulin Initiation in Japanese Patients With Type 2 Diabetes (JDDM 58): Model Development and Validation Study
by: Fujihara, Kazuya, et al.
Published: (2021-01-01)

Rates and risk factors for amputation in people with diabetes in Japan: a historical cohort study using a nationwide claims database
by: Masanori Kaneko, et al.
Published: (2021-04-01)

Superior socioeconomic status in patients with type 2 diabetes having gastric bypass surgery: a case-control analysis of 10 642 individuals
by: Kazuya Fujihara, et al.
Published: (2020-04-01)

Combination of diabetes mellitus and lack of habitual physical activity is a risk factor for functional disability in Japanese
by: Kazuya Fujihara, et al.
Published: (2020-04-01)

Thyroid Disorders and the Level of Malondialdehyde
by: Eham A. Ali, et al.
Published: (2009-04-01)

CREBH Regulates Systemic Glucose and Lipid Metabolism
by: Yoshimi Nakagawa, et al.
Published: (2018-05-01)

New perspective on type 2 diabetes, dyslipidemia and non‐alcoholic fatty liver disease
by: Takashi Matsuzaka, et al.
Published: (2020-05-01)

Antiproliferative and Antimigration Activities of Beauvericin Isolated from <i>Isaria</i> sp. on Pancreatic Cancer Cells
by: Hiroaki Yahagi, et al.
Published: (2020-10-01)

Study on the quantitative analysis and mutagenicity of malondialdehyde
by: SHI, ZHENG-AN, et al.
Published: (1988)

Reaction of Malondialdehyde with Some Biochemical Compounds
by: Wu, Yi-Chen, et al.
Published: (1998)

Natural antibodies to malondialdehyde adducts in atherosclerosis
by: Turunen, P. (Pauliina)
Published: (2013)

Ability of Current Machine Learning Algorithms to Predict and Detect Hypoglycemia in Patients With Diabetes Mellitus: Meta-analysis
by: Kodama, Satoru, et al.
Published: (2021-01-01)

The Placebo-Controlled Effect of Percutaneous Coronary Intervention on Exercise Induced Changes in Anti-Malondialdehyde-LDL Antibody Levels in Stable Coronary Artery Disease: A Substudy of the ORBITA Trial
by: Adam Hartley, et al.
Published: (2021-10-01)

Ethanol Extract of Marigold Flower (Tagetes Erecta L.) Decreases The Total Cholesterol, Low Density Lypoprotein (LDL), Malondialdehyde (MDA), and Apoliprotein B (APOB) on Hyperlipidemia Rat Models
by: I Nyoman Bagus Aji Kresnapati, et al.
Published: (2021-09-01)

Physical Fitness and Dyslipidemia Among Japanese: A Cohort Study From the Niigata Wellness Study
by: Haruki Momma, et al.
Published: (2021-04-01)

Increased cholesterol biosynthesis and hypercholesterolemia in mice overexpressing squalene synthase in the liver
by: Hiroaki Okazaki, et al.
Published: (2006-09-01)

Levels of Malondialdehyde and Superoxide Dismutase in Subclinical Hyperthyroidism
by: Ali Cetinkaya, et al.
Published: (2005-01-01)

Malondialdehyde Levels In Wilson′s Disease
by: Sinha Sanjib, et al.
Published: (2004-01-01)